Skip to content

Stefano Curti

  • Bachelor of economics
  • President and CEO
  • Venture capital and innovation incubator group

    Professional experience

    President and CEO

    Venture capital and innovation incubator group

    August 2013 - Present

    Global President

    Johnson & Johnson

    April 2011 - August 2013(2 years)

    President - US Beauty

    Johnson & Johnson USA

    February 2009 - March 2011(2 years)

    Regional Franchise Director

    Johnson & Johnson Europe, Middle East

    June 2002 - April 2004(2 years)


    Bachelor of economics

    LUISS Guido Carli - Libera Università Internazionale degli Studi Sociali

    January 1988 - January 1993(5 years)


    Benefiting from more than two decades of executive experience with the Johnson & Johnson Family of Consumer Companies (J&J), Stefano Curti currently leads a Silicon Valley-based incubator firm backed by venture capital, focused on the development and commercialization of innovation-driven consumer products. From April 2011 to August 2013, Stefano Curti was the Global President of the Skincare (Baby & Beauty) division of J&J. He guided business strategy for a multinational portfolio of products, which included brands such as Johnson's Baby, Neutrogena, Aveeno, Clean & Clear, Lubriderm, and many others. He particularly focused on enhancing sales and returns through restructuring the portfolio and product launch strategies. He also oversaw the acquisition of Elsker in China and spearheaded portfolio streamlining through divesting smaller brands. Mr. Curti earned his bachelor’s degree in economics at the Libera Università Internazionale degli Studi Sociali in Rome. He joined Johnson & Johnson in the early nineties and he was a UK-based regional franchise director, responsible for several of the firm’s Middle East, African, and European brands. Mr. Curti guided the acquisition of Coloplast Consumer Products A/S and the integration of the firm into J&J operations. Stefano Curti’s efforts significantly increased market share and revenue for the company in the Wound Care market within a two-year timeframe.